$MOTS
Motus GI Holdings Inc Stock $mots

$mots Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000149315223028452 Filed on August 14, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q2
Revenue	$86.00K	$113.0K	$185.0K
YoY Change	-69.06%	-38.92%	85.0%
Cost Of Revenue	$22.00K	$31.00K	$68.00K
YoY Change	-73.49%	-54.41%	61.9%
Gross Profit	$64.00K	$82.00K	$117.0K
YoY Change	-67.18%	-29.91%	101.72%
Gross Profit Margin	74.42%	72.57%	63.24%
Selling, General & Admin	$1.739M	$1.975M	$3.297M
YoY Change	-47.73%	-40.1%	5.0%
% of Gross Profit	2717.19%	2408.54%	2817.95%
Research & Development	$693.0K	$759.0K	$1.413M
YoY Change	-55.94%	-46.28%	-6.3%
% of Gross Profit	1082.81%	925.61%	1207.69%
Depreciation & Amortization	$110.0K	$113.0K	$129.0K
YoY Change	-14.06%	-12.4%	29.0%
% of Gross Profit	171.88%	137.8%	110.26%
Operating Expenses	$2.432M	$2.734M	$4.710M
YoY Change	-50.37%	-41.95%	1.33%
Operating Profit	-$2.394M	-$2.682M	-$4.593M
YoY Change	-49.12%	-41.61%	0.07%
Interest Expense	$281.0K	$285.0K	$356.0K
YoY Change	-16.86%	-19.94%	-334.21%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$2.680M	-$2.997M	-$5.140M
YoY Change	-46.01%	-41.69%	8.39%
Income Tax
% Of Pretax Income
Net Earnings	-$2.679M	-$2.997M	-$5.140M
YoY Change	-46.03%	-41.69%	8.39%
Net Earnings / Revenue	-3115.12%	-2652.21%	-2778.38%
Basic Earnings Per Share	-$4.28	-$0.40	-$1.86
Diluted Earnings Per Share	-$4.28	-$0.40	-$1.863M
COMMON SHARES
Basic Shares Outstanding	5.893M shares	4.779M shares
Diluted Shares Outstanding	626.5K shares	7.556M shares	2.758M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.720M	$8.521M	$15.76M
YoY Change	-56.97%	-45.92%	-40.27%
Cash & Equivalents	$5.700M	$8.500M	$15.76M
Short-Term Investments
Other Short-Term Assets	$510.0K	$737.0K	$1.317M
YoY Change	-49.9%	-44.04%	53.32%
Inventory	$781.0K	$823.0K	$1.038M
Prepaid Expenses
Receivables	$102.0K	$106.0K	$81.00K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$6.742M	$9.810M	$18.19M
YoY Change	-56.47%	-46.08%	-35.06%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.101M	$1.209M	$1.329M
YoY Change	-21.08%	-9.03%	-38.56%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$13.00K	$13.00K	$13.00K
YoY Change	0.0%	0.0%	0.0%
Total Long-Term Assets	$1.749M	$1.931M	$1.889M
YoY Change	-6.92%	2.22%	-13.19%
TOTAL ASSETS
Total Short-Term Assets	$6.742M	$9.810M	$18.19M
Total Long-Term Assets	$1.749M	$1.931M	$1.889M
Total Assets	$8.491M	$11.74M	$20.08M
YoY Change	-51.11%	-41.53%	-33.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.470M	$1.470M	$2.212M
YoY Change	-45.47%	-33.54%	2.88%
Accrued Expenses	$220.0K	$243.0K	$266.0K
YoY Change	-11.29%	-8.65%	1.92%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.781M	$2.694M	$1.757M
YoY Change	13.37%	53.33%	-77.99%
Total Short-Term Liabilities	$4.529M	$4.451M	$4.253M
YoY Change	-17.16%	4.66%	-59.11%
LONG-TERM LIABILITIES
Long-Term Debt	$2.470M	$3.198M	$5.892M
YoY Change	-52.96%	-45.72%
Other Long-Term Liabilities	$30.00K	$1.135M	$2.103M
YoY Change	-98.51%	-46.03%	-4.45%
Total Long-Term Liabilities	$2.470M	$3.198M	$5.892M
YoY Change	-52.96%	-45.72%	167.7%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.529M	$4.451M	$4.253M
Total Long-Term Liabilities	$2.470M	$3.198M	$5.892M
Total Liabilities	$10.97M	$12.70M	$16.11M
YoY Change	-33.94%	-21.14%	27.84%
SHAREHOLDERS EQUITY
Retained Earnings	-$151.4M	-$148.7M	-$132.7M
YoY Change	9.97%	12.05%
Common Stock	$0.00	$1.000K	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$2.478M	-$963.0K	$3.972M
YoY Change
Total Liabilities & Shareholders Equity	$8.491M	$11.74M	$20.08M
YoY Change	-51.11%	-41.53%	-33.49%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	-$2.679M	-$2.997M	-$5.140M
YoY Change	-46.03%	-41.69%	8.39%
Depreciation, Depletion And Amortization	$110.0K	$113.0K	$129.0K
YoY Change	-14.06%	-12.4%	29.0%
Cash From Operating Activities	-$1.970M	-$2.571M	-$4.565M
YoY Change	-45.55%	-43.68%	49.43%
INVESTING ACTIVITIES
Capital Expenditures	$10.00K	$49.00K	-$48.00K
YoY Change	-106.02%	-202.08%	-62.79%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$10.00K	-$49.00K	-$48.00K
YoY Change	-93.98%	2.08%	-62.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-820.0K	2.493M	32.00K
YoY Change	-162.07%	7690.62%	-98.24%
NET CHANGE
Cash From Operating Activities	-1.970M	-2.571M	-4.565M
Cash From Investing Activities	-10.00K	-49.00K	-48.00K
Cash From Financing Activities	-820.0K	2.493M	32.00K
Net Change In Cash	-2.800M	-127.0K	-4.581M
YoY Change	13.68%	-97.23%	234.38%
FREE CASH FLOW
Cash From Operating Activities	-$1.970M	-$2.571M	-$4.565M
Capital Expenditures	$10.00K	$49.00K	-$48.00K
Free Cash Flow	-$1.980M	-$2.620M	-$4.517M
YoY Change	-42.64%	-42.0%	54.37%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001686850
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse		usd
	MOTS	Issuance Of Common Stock For Board Of Directors Compensation IssuanceOfCommonStockForBoardOfDirectorsCompensation		usd
	MOTS	Gross Proceeds From Private Placement Offering GrossProceedsFromPrivatePlacementOffering		usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt		usd
	MOTS	Common Stock Issued To Settle Accrued Expenses For Board Of Directors Compensation CommonStockIssuedToSettleAccruedExpensesForBoardOfDirectorsCompensation		usd
	MOTS	Common Stock Issued To Settle Accrued Expenses For Board Of Directors Compensation CommonStockIssuedToSettleAccruedExpensesForBoardOfDirectorsCompensation		usd
	MOTS	Common Stock Issued For Prepaid Board Of Directors Compensation CommonStockIssuedForPrepaidBoardOfDirectorsCompensation		usd
	MOTS	Purchase Of Fixed Assets In Prepaid Expenses PurchaseOfFixedAssetsInPrepaidExpenses		usd
	MOTS	Noncash Issuance Costs From Private Placement NoncashIssuanceCostsFromPrivatePlacement		usd
	MOTS	Prepaid Expenses Resulting From Rightofuse Asset Obtained PrepaidExpensesResultingFromRightofuseAssetObtained		usd
CY2022Q4	MOTS	Restructuring Liabilities RestructuringLiabilities		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38389
	dei	Entity Registrant Name EntityRegistrantName	Motus GI Holdings, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	81-4042793
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1301 East Broward Boulevard
	dei	Entity Address Address Line2 EntityAddressAddressLine2	3rd Floor
	dei	Entity Address City Or Town EntityAddressCityOrTown	Ft. Lauderdale
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33301
	dei	City Area Code CityAreaCode	(954)
	dei	Local Phone Number LocalPhoneNumber	541 8000
	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value per share
	dei	Trading Symbol TradingSymbol	MOTS
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5893453	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8521000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14042000	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	106000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	59000	usd
CY2023Q2	MOTS	Inventory Current InventoryCurrent	446000	usd
CY2022Q4	MOTS	Inventory Current InventoryCurrent	488000	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	737000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	781000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	9810000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	15370000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1209000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1325000	usd
CY2023Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	377000	usd
CY2022Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	511000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	332000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	428000	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	13000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	13000	usd
CY2023Q2	us-gaap	Assets Assets	11741000	usd
CY2022Q4	us-gaap	Assets Assets	17647000	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	151000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	182000	usd
CY2023Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	2694000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2532000	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1470000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1969000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	243000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	245000	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	44000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	53000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	4451000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4799000	usd
CY2023Q2	MOTS	Convertible Debt Unamortized Discount Noncurrent ConvertibleDebtUnamortizedDiscountNoncurrent	80000	usd
CY2022Q4	MOTS	Convertible Debt Unamortized Discount Noncurrent ConvertibleDebtUnamortizedDiscountNoncurrent	108000	usd
CY2023Q2	MOTS	Convertible Note Noncurrent ConvertibleNoteNoncurrent	3920000	usd
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	6167271	shares
CY2022Q4	MOTS	Convertible Note Noncurrent ConvertibleNoteNoncurrent	3892000	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	70000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	135000	usd
CY2023Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3198000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	4589000	usd
CY2023Q2	MOTS	Contingent Royalty Obligation ContingentRoyaltyObligation	1056000	usd
CY2022Q4	MOTS	Contingent Royalty Obligation ContingentRoyaltyObligation	1212000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	79000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	178000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	12704000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	14670000	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	115000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	115000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5305441	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5305441	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4659769	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4659769	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	147770000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	144328000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-148734000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-141351000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-963000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2977000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11741000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17647000	usd
CY2023Q2	us-gaap	Revenues Revenues	113000	usd
CY2022Q2	us-gaap	Revenues Revenues	185000	usd
	us-gaap	Revenues Revenues	169000	usd
	us-gaap	Revenues Revenues	205000	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	31000	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	68000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	40000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	83000	usd
CY2023Q2	MOTS	Costs Of Revenue Impairment Of Inventory CostsOfRevenueImpairmentOfInventory	30000	usd
	MOTS	Costs Of Revenue Impairment Of Inventory CostsOfRevenueImpairmentOfInventory	195000	usd
	MOTS	Costs Of Revenue Impairment Of Inventory CostsOfRevenueImpairmentOfInventory	159000	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	759000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1413000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2213000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2688000	usd
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	337000	usd
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1222000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1179000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2205000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1638000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2075000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3583000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4189000	usd
CY2023Q2	us-gaap	Costs And Expenses CostsAndExpenses	2795000	usd
CY2022Q2	us-gaap	Costs And Expenses CostsAndExpenses	4778000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	7210000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	9324000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2682000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-4593000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7041000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9119000	usd
CY2023Q2	MOTS	Loss On Changes In Fair Value Of Contingent Royalty Obligation LossOnChangesInFairValueOfContingentRoyaltyObligation	64000	usd
CY2022Q2	MOTS	Loss On Changes In Fair Value Of Contingent Royalty Obligation LossOnChangesInFairValueOfContingentRoyaltyObligation	92000	usd
	MOTS	Loss On Changes In Fair Value Of Contingent Royalty Obligation LossOnChangesInFairValueOfContingentRoyaltyObligation	-156000	usd
	MOTS	Loss On Changes In Fair Value Of Contingent Royalty Obligation LossOnChangesInFairValueOfContingentRoyaltyObligation	63000	usd
CY2023Q2	MOTS	Finance Income Expense Net FinanceIncomeExpenseNet	246000	usd
CY2022Q2	MOTS	Finance Income Expense Net FinanceIncomeExpenseNet	359000	usd
	MOTS	Finance Income Expense Net FinanceIncomeExpenseNet	485000	usd
	MOTS	Finance Income Expense Net FinanceIncomeExpenseNet	691000	usd
CY2023Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-5000	usd
CY2022Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-96000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-13000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-78000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2997000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-5140000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7383000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-9951000	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.40
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.40
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.86
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.86
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.20
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.20
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.72
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.72
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.40
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.86
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.20
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.72
CY2023Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	7555903	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7555903	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	2758457	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2758457	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6167271	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	2674536	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2674536	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	7555903	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	2758457	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	6167271	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	2674536	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2977000	usd
CY2023Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	19000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	102000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	222000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-4386000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-1085000	usd
CY2023Q2	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	731000	usd
CY2023Q2	MOTS	Stock Issued During Period Value Private Placement Offering Net Of Financing Fees StockIssuedDuringPeriodValuePrivatePlacementOfferingNetOfFinancingFees	3070000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	49000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2997000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-963000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	9657000	usd
CY2022Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	111000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3004000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	235000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	521000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-4811000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	8606000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	8606000	usd
CY2022Q2	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	5000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	45000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	461000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-5140000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	3972000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	3972000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7383000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-9951000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	230000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	253000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	123000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	125000	usd
	MOTS	Gain Loss On Change In Estimated Fair Value Of Contingent Royalty Obligation GainLossOnChangeInEstimatedFairValueOfContingentRoyaltyObligation	156000	usd
	MOTS	Gain Loss On Change In Estimated Fair Value Of Contingent Royalty Obligation GainLossOnChangeInEstimatedFairValueOfContingentRoyaltyObligation	-63000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	271000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	982000	usd
	MOTS	Impairment Of Inventory ImpairmentOfInventory	195000	usd
	MOTS	Impairment Of Inventory ImpairmentOfInventory	159000	usd
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	36000	usd
	MOTS	Issuance Of Common Stock For Board Of Directors Compensation IssuanceOfCommonStockForBoardOfDirectorsCompensation	118000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	121000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	175000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	47000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-28000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	33000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	764000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-44000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	407000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-604000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-459000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-125000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-177000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-9000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	8000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7373000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9811000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	88000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	49000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-88000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-49000	usd
	MOTS	Gross Proceeds From Private Placement Offering GrossProceedsFromPrivatePlacementOffering	3537000	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	1325000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	121000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3165000	usd
	MOTS	Equity Financing Fees EquityFinancingFees	-393000	usd
	MOTS	Equity Financing Fees EquityFinancingFees	-111000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1940000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3054000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5521000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6806000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14042000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	22563000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8521000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	15757000	usd
	us-gaap	Interest Paid Net InterestPaidNet	476000	usd
	us-gaap	Interest Paid Net InterestPaidNet	511000	usd
	MOTS	Common Stock Issued For Prepaid Board Of Directors Compensation CommonStockIssuedForPrepaidBoardOfDirectorsCompensation	117000	usd
	MOTS	Purchase Of Fixed Assets In Prepaid Expenses PurchaseOfFixedAssetsInPrepaidExpenses	4000	usd
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	14000	usd
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	62000	usd
	MOTS	Purchase Of Property And Equipment In Accounts Payable And Accrued Expenses PurchaseOfPropertyAndEquipmentInAccountsPayableAndAccruedExpenses	12000	usd
	MOTS	Purchase Of Property And Equipment In Accounts Payable And Accrued Expenses PurchaseOfPropertyAndEquipmentInAccountsPayableAndAccruedExpenses	75000	usd
	MOTS	Financing Fees Included In Accounts Payable And Accrued Expenses FinancingFeesIncludedInAccountsPayableAndAccruedExpenses	93000	usd
	MOTS	Financing Fees Included In Accounts Payable And Accrued Expenses FinancingFeesIncludedInAccountsPayableAndAccruedExpenses	5000	usd
	MOTS	Noncash Issuance Costs From Private Placement NoncashIssuanceCostsFromPrivatePlacement	264000	usd
	MOTS	Rightofuse Asset Obtained In Exchange For Lease Obligation RightofuseAssetObtainedInExchangeForLeaseObligation	35000	usd
	MOTS	Rightofuse Asset Obtained In Exchange For Lease Obligation RightofuseAssetObtainedInExchangeForLeaseObligation	34000	usd
	MOTS	Prepaid Expenses Resulting From Rightofuse Asset Obtained PrepaidExpensesResultingFromRightofuseAssetObtained	3000	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80A_eus-gaap--NatureOfOperations_zju25ic0hP72" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 1 – <span id="xdx_825_zYgnCi8ndNx9">Description of Business</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Motus GI Holdings, Inc. (the “Company”) was incorporated in Delaware, U.S.A. in September 2016. The Company and its subsidiaries, Motus GI Technologies, Ltd. and Motus GI, LLC, are collectively referred to as “Motus GI” or the “Company”.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has developed the Pure-Vu System, a medical device that has been cleared by the U.S. Food and Drug Administration (the “FDA”) to help facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal (“GI”) endoscopy procedures. The Pure-Vu System has received a CE Mark in the EU for use in colonoscopy. The Pure-Vu System integrates with standard and slim colonoscopes, as well as gastroscopes, to improve visualization during colonoscopy and upper GI procedures while preserving established procedural workflow and techniques. Through irrigation and evacuation of debris, the Pure-Vu System is designed to provide better-quality exams. The Company received 510(k) clearance in February 2022 from the FDA for the Pure-Vu EVS System and has commenced commercialization of this product. The Company does not expect to generate significant revenue from product sales until it further expands its commercialization efforts, which is subject to significant uncertainty.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
	us-gaap	Net Income Loss NetIncomeLoss	-7400000	usd
	MOTS	Net Cash Used In Operating Activities NetCashUsedInOperatingActivities	-7300000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8500000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-148700000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84D_eus-gaap--UseOfEstimates_zSKxpwZV8KE" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zbERwkYtCat8">Use of estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5001276	shares
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	827101	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5001276	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	827101	shares
	MOTS	Rate Of Royalty Payment RateOfRoyaltyPayment	0.03	pure
CY2022	MOTS	Rate Of Royalty Payment RateOfRoyaltyPayment	0.03	pure
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1209000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1325000	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	113000	usd
	us-gaap	Servicing Liability At Fair Value Description Of Other Changes In Fair Value ServicingLiabilityAtFairValueDescriptionOfOtherChangesInFairValue	The Company recalculated the fair value of the liability by applying a +/- 2% change to the input variable in the discounted cash flow model; the discount rate. A 2% decrease in the discount rate would increase the liability by $95 and a 2% increase in the discount rate would decrease the liability by $86. Such amounts are based on highly sensitive estimates and actual results could result in material change in future periods
CY2023Q2	MOTS	Cost Of Revenue Impairment Of Inventory CostOfRevenueImpairmentOfInventory	30000	usd
	MOTS	Cost Of Revenue Impairment Of Inventory CostOfRevenueImpairmentOfInventory	195000	usd
CY2022Q2	MOTS	Cost Of Revenue Impairment Of Inventory CostOfRevenueImpairmentOfInventory	0	usd
	MOTS	Cost Of Revenue Impairment Of Inventory CostOfRevenueImpairmentOfInventory	159000	usd
CY2023Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	553000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	697000	usd
CY2023Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	177000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	155000	usd
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	689000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	548000	usd
CY2023Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	596000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	401000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	823000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	999000	usd
CY2023Q2	MOTS	Inventory Current InventoryCurrent	446000	usd
CY2022Q4	MOTS	Inventory Current InventoryCurrent	488000	usd
CY2023Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	377000	usd
CY2022Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	511000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3332000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3218000	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2123000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1893000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	230000	usd
CY2022Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	129000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	253000	usd
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	2000	usd
CY2022Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	23000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	18000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	62000	usd
CY2023Q2	us-gaap	Variable Lease Cost VariableLeaseCost	39000	usd
CY2022Q2	us-gaap	Variable Lease Cost VariableLeaseCost	30000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	64000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	60000	usd
CY2023Q2	us-gaap	Lease Cost LeaseCost	41000	usd
CY2022Q2	us-gaap	Lease Cost LeaseCost	53000	usd
	us-gaap	Lease Cost LeaseCost	82000	usd
	us-gaap	Lease Cost LeaseCost	122000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	332000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	428000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	243000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	245000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	79000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	178000	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	322000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	423000	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y5M8D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y9M14D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0730	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0736	pure
CY2023Q2	us-gaap	Direct Taxes And Licenses Costs DirectTaxesAndLicensesCosts	60000	usd
CY2022Q2	us-gaap	Direct Taxes And Licenses Costs DirectTaxesAndLicensesCosts	60000	usd
	us-gaap	Direct Taxes And Licenses Costs DirectTaxesAndLicensesCosts	109000	usd
	us-gaap	Direct Taxes And Licenses Costs DirectTaxesAndLicensesCosts	107000	usd
	us-gaap	Interest Expense Other InterestExpenseOther	470000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	123000	usd
	us-gaap	Interest Expense InterestExpense	593000	usd
CY2023Q2	us-gaap	Interest Expense Other InterestExpenseOther	224000	usd
CY2023Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	61000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	285000	usd
	us-gaap	Manufacturing Costs ManufacturingCosts	38000	usd
CY2023Q2	MOTS	License Fees LicenseFees	60000	usd
	MOTS	License Fees LicenseFees	109000	usd
CY2022Q2	MOTS	License Fees LicenseFees	60000	usd
	MOTS	License Fees LicenseFees	107000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	49000	usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	461000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	271000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	982000	usd
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.0001
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	26	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	525000	shares
CY2023Q1	us-gaap	Restructuring And Related Cost Description RestructuringAndRelatedCostDescription	the Company commenced a strategic restructuring program aimed at capital preservation. In April 2023, the Company approved the implementation of additional cost cutting measures, including an executive reorganization and other cuts in clinical expenses, in connection with its ongoing efforts to reduce operating expenses. In addition, the non-management members of the Board agreed to defer their Board fees until a future date
CY2023Q2	us-gaap	Payments For Restructuring PaymentsForRestructuring	416000	usd
	us-gaap	Payments For Restructuring PaymentsForRestructuring	1423000	usd
CY2023Q2	us-gaap	Restructuring Charges RestructuringCharges	94000	usd
	us-gaap	Payments For Restructuring PaymentsForRestructuring	1423000	usd
CY2023Q2	MOTS	Restructuring Liabilities RestructuringLiabilities	94000	usd

Files In Submission

Name	View Source	Status
mots-20230630_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
mots-20230630_pre.xml	Edgar Link	unprocessable
0001493152-23-028452-index-headers.html	Edgar Link	pending
0001493152-23-028452-index.html	Edgar Link	pending
0001493152-23-028452.txt	Edgar Link	pending
0001493152-23-028452-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex31-3.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mots-20230630.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
mots-20230630_lab.xml	Edgar Link	unprocessable
mots-20230630_def.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MOTS
Motus GI Holdings Inc Stock $mots

2023 Q3 Form 10-Q Financial Statement

#000149315223028452 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MOTS Motus GI Holdings Inc Stock $mots

2023 Q3 Form 10-Q Financial Statement

#000149315223028452 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MOTS
Motus GI Holdings Inc Stock $mots